Pro-Pointer, Inc. Introduces a Revolutionary Approach to Weight Management
February 12 2010 - 4:05PM
Marketwired
Pro Pointer, Inc. (PINKSHEETS: PPII), through its wholly owned
subsidiary Coenzyme-A Technologies, Inc., is pleased to announce
its innovative proprietary COENZYME-A MODULATOR MATRIX II™ to the
creation of a nutraceutical product that contains a balanced
combination of active nutritional components that support the
body's natural management of fat. "BODY IMAGE™," in conjunction
with proper diet and exercise, can produce phenomenal results in
fat loss, while maintaining energy levels and preventing hunger and
weakness. "BODY IMAGE™" is the first nutraceutical product to
combine nutritional components that can be used by the body to
support its manufacture and utilization of Coenzyme-A (the Master
Coenzyme) with a specific set of substrates that are designed to
assist the body in metabolizing fat.
ABOUT COENZYME-A TECHNOLOGIES, INC. -- Coenzyme-A Technologies,
Inc. is an innovative company that has applied new technology to
the formulation and manufacture of a series of proprietary products
which address nutritional deficiencies that result from the stress
of modern day living, chemical imbalances within the body, and the
effects of aging. Coenzyme-A is the first nutraceutical product to
combine nutritional components that can be successfully used by the
body to support its manufacture and utilization of cellular
Coenzyme-A (The Master Coenzyme). Coenzyme-A contains a specific
set of substrates that are designed to assist the body in
converting fats, carbohydrates and proteins into energy at the
cellular level. See Company website -- www.coenzyme-a.com.
FORWARD LOOKING STATEMENTS
The information contained in this news release, other than
historical information, consists of forward-looking statements
within the meaning of Section 27A of the Securities Act and Section
21E of the Exchange Act. These statements may involve risks and
uncertainties that could cause actual results to differ materially
from those described in such statements. Such forward-looking
statements involve known and unknown risks and uncertainties,
including all business uncertainties relating to product
development, marketing, market acceptance, future capital
requirements, competition in general and other factors that may
cause actual results to be materially different from those
described herein as anticipated, believed, estimated or expected.
The Company is under no obligation to (and expressly disclaims any
such obligation to) update or alter its forward-looking statements
whether as a result of new information, future events or
otherwise.
Add to Digg Bookmark with del.icio.us Add to Newsvine
INVESTOR RELATIONS at: InvestSource, Inc. 6352 Santa Ynez Dr.
Huntington Beach, CA 92647 Phone (714) 847-2460 fax (714)
847-4987
Coenzyme A (CE) (USOTC:PPII)
Historical Stock Chart
From Nov 2024 to Dec 2024
Coenzyme A (CE) (USOTC:PPII)
Historical Stock Chart
From Dec 2023 to Dec 2024
Real-Time news about Coenzyme A Inc (CE) (OTCMarkets): 0 recent articles
More Pro-Pointer, Inc. News Articles